Advertisement
YOU ARE HERE: LAT HomeCollectionsInsulin
IN THE NEWS

Insulin

HEALTH
October 26, 2009 | Marni Jameson
Simply put, diabetes is a contest between people and their blood. For people whose bodies don't produce enough insulin to manage their blood sugar, the goal is a normal blood score, achieved through a balancing act of lifestyle and medication. "Eventually most patients will follow a course of lifestyle, medications, then insulin," said Dr. Enrico Cagliero, referring to people diagnosed with the most common form of diabetes, known as Type 2. He's an endocrinologist at Massachusetts General Hospital and associate professor of medicine at Harvard Medical School.
Advertisement
CALIFORNIA | LOCAL
July 17, 1989 | From staff and wire reports
Diabetics given a new pancreas to eliminate the need for insulin shots may also end up with healthier kidneys, six Minneapolis doctors reported last week in the New England Journal of Medicine. The discovery supports a long-held belief that if diabetics could carefully control their blood-sugar level, they might be able to avoid the kidney failure, blindness and other serious health problems that appear in many longtime sufferers of the disease.
CALIFORNIA | LOCAL
September 24, 1986 | MARCIDA DODSON, Times Staff Writer
In the first trial studies of their kind in the United States, diabetes specialists from UC Irvine and Johns Hopkins University have been given approval by the U.S. Food and Drug Administration to surgically implant insulin pumps, UCI officials said Tuesday.
NEWS
June 22, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
Supreme Court Justice Sonia Sotomayor spoke out this week about her Type 1 diabetes, calling attention to the issue—a condition that as many as 3 million Americans know well. The pinpricks for blood, the glucose monitors, the insulin injections… Daily life isn’t easy, the Supreme Court justice told a gathering of children with diabetes. An online diabetic community would seem to agree. This from the blog Cure Moll : “When I was 10, my mom and I were used to shots, we knew the perfect amount of insulin for everything, from a small piece of pizza and cake at a birthday party to simply cereal for breakfast.
NEWS
December 1, 2011 | By Eryn Brown, Los Angeles Times / For the Booster Shots blog
On Thursday the Food and Drug Administration issued draft guidelines for researchers and manufacturers working to develop and build an artificial pancreas to help patients with Type 1 diabetes control their blood sugar. About 3 million Americans have Type 1 diabetes, which develops when cells in the pancreas stop producing enough insulin to control blood sugar.  Patients with the disease must monitor their blood glucose aggressively.  If it goes too high, they have to carefully calculate how much insulin they need to bring it in line -- and then get an injection.  If a person with Type 1 diabetes' blood sugar drops too low, he or she could require a dose of another hormone, glucagon, to raise it back up. The unrelenting and error-prone process can be exhausting, so patient advocacy groups such as the Juvenile Diabetes Research Foundation have been pushing the development of an artificial pancreas that would tightly control blood sugar levels much as the actual organ: monitoring glucose levels continually and automatically delivering the right dose of insulin, through a pump, into the body.  The system would work by connecting the monitoring system to a computer, which in turn would calculate the correct insulin dose and send a signal to the insulin pump to deliver the needed hormones.
SCIENCE
May 30, 2002 | THOMAS H. MAUGH II, TIMES STAFF WRITER
Scientists have delayed the onset of full-blown Type 1 diabetes in young people for at least a year with a two-week drug treatment that blocked a specific part of the youths' immune systems. Patients taking the drug continued to produce their own insulin and required fewer and smaller insulin shots than those who were not treated, according to a study published today in the New England Journal of Medicine.
Los Angeles Times Articles
|